medicines 4 u ltd Company Information
Company Number
05455835
Next Accounts
Feb 2025
Industry
Dispensing chemist in specialised stores
Shareholders
m4u holdings ltd
Group Structure
View All
Contact
Registered Address
2nd floor grove house, 55 lowlands road, harrow, HA1 3AW
medicines 4 u ltd Estimated Valuation
Pomanda estimates the enterprise value of MEDICINES 4 U LTD at £1.7m based on a Turnover of £4.5m and 0.37x industry multiple (adjusted for size and gross margin).
medicines 4 u ltd Estimated Valuation
Pomanda estimates the enterprise value of MEDICINES 4 U LTD at £4.1m based on an EBITDA of £895.4k and a 4.58x industry multiple (adjusted for size and gross margin).
medicines 4 u ltd Estimated Valuation
Pomanda estimates the enterprise value of MEDICINES 4 U LTD at £8.3m based on Net Assets of £3.7m and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medicines 4 U Ltd Overview
Medicines 4 U Ltd is a live company located in harrow, HA1 3AW with a Companies House number of 05455835. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in May 2005, it's largest shareholder is m4u holdings ltd with a 100% stake. Medicines 4 U Ltd is a mature, small sized company, Pomanda has estimated its turnover at £4.5m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medicines 4 U Ltd Health Check
Pomanda's financial health check has awarded Medicines 4 U Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
4 Weak
Size
annual sales of £4.5m, make it smaller than the average company (£11.5m)
- Medicines 4 U Ltd
£11.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (6%)
- Medicines 4 U Ltd
6% - Industry AVG
Production
with a gross margin of 32.6%, this company has a comparable cost of product (32.6%)
- Medicines 4 U Ltd
32.6% - Industry AVG
Profitability
an operating margin of 19.3% make it more profitable than the average company (3.2%)
- Medicines 4 U Ltd
3.2% - Industry AVG
Employees
with 25 employees, this is below the industry average (74)
25 - Medicines 4 U Ltd
74 - Industry AVG
Pay Structure
on an average salary of £25.3k, the company has an equivalent pay structure (£25.3k)
- Medicines 4 U Ltd
£25.3k - Industry AVG
Efficiency
resulting in sales per employee of £181.2k, this is more efficient (£144.4k)
- Medicines 4 U Ltd
£144.4k - Industry AVG
Debtor Days
it gets paid by customers after 61 days, this is later than average (30 days)
- Medicines 4 U Ltd
30 days - Industry AVG
Creditor Days
its suppliers are paid after 66 days, this is close to average (65 days)
- Medicines 4 U Ltd
65 days - Industry AVG
Stock Days
it holds stock equivalent to 14 days, this is less than average (36 days)
- Medicines 4 U Ltd
36 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 39 weeks, this is more cash available to meet short term requirements (15 weeks)
39 weeks - Medicines 4 U Ltd
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 20.3%, this is a lower level of debt than the average (58.2%)
20.3% - Medicines 4 U Ltd
58.2% - Industry AVG
MEDICINES 4 U LTD financials
Medicines 4 U Ltd's latest turnover from May 2023 is estimated at £4.5 million and the company has net assets of £3.7 million. According to their latest financial statements, Medicines 4 U Ltd has 25 employees and maintains cash reserves of £710.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 25 | 24 | 22 | 21 | 21 | 20 | 20 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 179,182 | 198,374 | 224,359 | 259,546 | 278,340 | 290,848 | 272,871 | 258,405 | 283,249 | 290,262 | 321,704 | 353,652 | 360,865 | 390,852 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 26,422 | 126,824 | 227,226 | 383,990 | 493,891 | 629,697 | 702,964 | 681,238 | 748,172 |
Investments & Other | 516,475 | 602,088 | 447,088 | 447,088 | 311,413 | 304,363 | 304,363 | 304,363 | 4,313 | 4,313 | 4,349 | 4,349 | 4,349 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 695,657 | 800,462 | 671,447 | 706,634 | 589,753 | 621,633 | 704,058 | 789,994 | 671,552 | 788,466 | 955,750 | 1,060,965 | 1,046,452 | 1,139,024 |
Stock & work in progress | 120,961 | 112,861 | 113,047 | 118,736 | 113,330 | 120,263 | 96,199 | 116,147 | 190,042 | 204,688 | 303,517 | 248,641 | 125,277 | 122,423 |
Trade Debtors | 763,007 | 653,234 | 864,842 | 809,047 | 414,351 | 871,450 | 817,407 | 689,675 | 732,389 | 504,716 | 420,773 | 846,259 | 838,476 | 518,999 |
Group Debtors | 335,730 | 144,558 | 77,403 | 126,429 | 154,427 | 117,547 | 586,440 | 389,836 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 2,035,126 | 1,560,417 | 1,110,137 | 904,445 | 823,288 | 638,400 | 41,792 | 49,739 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 710,616 | 646,432 | 707,616 | 251,558 | 267,831 | 103,934 | 82,174 | 204,468 | 386,988 | 446,664 | 612,371 | 250,172 | 650,973 | 540,028 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 3,965,440 | 3,117,502 | 2,873,045 | 2,210,215 | 1,773,227 | 1,851,594 | 1,624,012 | 1,449,865 | 1,309,419 | 1,156,068 | 1,336,661 | 1,345,072 | 1,614,726 | 1,181,450 |
total assets | 4,661,097 | 3,917,964 | 3,544,492 | 2,916,849 | 2,362,980 | 2,473,227 | 2,328,070 | 2,239,859 | 1,980,971 | 1,944,534 | 2,292,411 | 2,406,037 | 2,661,178 | 2,320,474 |
Bank overdraft | 0 | 0 | 54,678 | 0 | 0 | 25,281 | 18,710 | 18,710 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 23,407 | 18,710 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 557,779 | 556,018 | 486,335 | 560,127 | 379,520 | 630,546 | 574,311 | 527,531 | 941,402 | 1,125,526 | 1,644,456 | 1,381,771 | 1,534,969 | 1,170,189 |
Group/Directors Accounts | 0 | 92,071 | 87,275 | 27,949 | 2,934 | 47,836 | 172,838 | 115,147 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 2,040 | 6,460 | 10,879 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 386,784 | 231,386 | 317,881 | 189,081 | 102,895 | 141,682 | 46,591 | 57,577 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 944,563 | 881,515 | 952,629 | 811,443 | 504,059 | 845,345 | 812,450 | 718,965 | 941,402 | 1,125,526 | 1,644,456 | 1,381,771 | 1,534,969 | 1,170,189 |
loans | 0 | 0 | 0 | 50,000 | 23,407 | 42,117 | 60,808 | 79,518 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 98,228 | 140,007 | 135,648 | 534,026 | 501,464 | 631,329 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 50,000 | 23,407 | 42,117 | 60,808 | 79,518 | 98,228 | 140,007 | 135,648 | 534,026 | 501,464 | 631,329 |
total liabilities | 944,563 | 881,515 | 952,629 | 861,443 | 527,466 | 887,462 | 873,258 | 798,483 | 1,039,630 | 1,265,533 | 1,780,104 | 1,915,797 | 2,036,433 | 1,801,518 |
net assets | 3,716,534 | 3,036,449 | 2,591,863 | 2,055,406 | 1,835,514 | 1,585,765 | 1,454,812 | 1,441,376 | 941,341 | 679,001 | 512,307 | 490,240 | 624,745 | 518,956 |
total shareholders funds | 3,716,534 | 3,036,449 | 2,591,863 | 2,055,406 | 1,835,514 | 1,585,765 | 1,454,812 | 1,441,376 | 941,341 | 679,001 | 512,307 | 490,240 | 624,745 | 518,956 |
May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 19,192 | 30,950 | 36,155 | 40,917 | 42,550 | 378,035 | 25,586 | 27,298 | 30,689 | 27,016 | 23,652 | 31,759 | 27,581 | 33,761 |
Amortisation | 0 | 0 | 0 | 0 | 26,422 | 100,402 | 100,402 | 109,318 | 109,901 | 135,806 | 73,267 | 73,267 | 66,934 | 66,934 |
Tax | ||||||||||||||
Stock | 8,100 | -186 | -5,689 | 5,406 | -6,933 | 24,064 | -19,948 | -73,895 | -14,646 | -98,829 | 54,876 | 123,364 | 2,854 | 122,423 |
Debtors | 775,654 | 305,827 | 212,461 | 447,855 | -235,331 | 181,758 | 316,389 | 396,861 | 227,673 | 83,943 | -425,486 | 7,783 | 319,477 | 518,999 |
Creditors | 1,761 | 69,683 | -73,792 | 180,607 | -251,026 | 56,235 | 46,780 | -413,871 | -184,124 | -518,930 | 262,685 | -153,198 | 364,780 | 1,170,189 |
Accruals and Deferred Income | 155,398 | -86,495 | 128,800 | 86,186 | -38,787 | 95,091 | -10,986 | 57,577 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | -85,613 | 155,000 | 0 | 135,675 | 7,050 | 0 | 0 | 300,050 | 0 | -36 | 0 | 0 | 4,349 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | -23,407 | 4,697 | 18,710 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -92,071 | 4,796 | 59,326 | 25,015 | -44,902 | -125,002 | 57,691 | 115,147 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | -50,000 | 26,593 | -18,710 | -18,691 | -18,710 | 79,518 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | -2,040 | -4,420 | -4,419 | 10,879 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -98,228 | -41,779 | 4,359 | -398,378 | 32,562 | -129,865 | 631,329 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | 64,184 | -61,184 | 456,058 | -16,273 | 163,897 | 21,760 | -122,294 | -182,520 | -59,676 | -165,707 | 362,199 | -400,801 | 110,945 | 540,028 |
overdraft | 0 | -54,678 | 54,678 | 0 | -25,281 | 6,571 | 0 | 18,710 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 64,184 | -6,506 | 401,380 | -16,273 | 189,178 | 15,189 | -122,294 | -201,230 | -59,676 | -165,707 | 362,199 | -400,801 | 110,945 | 540,028 |
medicines 4 u ltd Credit Report and Business Information
Medicines 4 U Ltd Competitor Analysis
Perform a competitor analysis for medicines 4 u ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HA1 area or any other competitors across 12 key performance metrics.
medicines 4 u ltd Ownership
MEDICINES 4 U LTD group structure
Medicines 4 U Ltd has 1 subsidiary company.
Ultimate parent company
1 parent
MEDICINES 4 U LTD
05455835
1 subsidiary
medicines 4 u ltd directors
Medicines 4 U Ltd currently has 2 directors. The longest serving directors include Mr Anil Sharma (May 2005) and Mrs Geeta Sharma (Jun 2015).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Anil Sharma | 51 years | May 2005 | - | Director | |
Mrs Geeta Sharma | England | 47 years | Jun 2015 | - | Director |
P&L
May 2023turnover
4.5m
+9%
operating profit
876.2k
0%
gross margin
32.6%
-3.6%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2023net assets
3.7m
+0.22%
total assets
4.7m
+0.19%
cash
710.6k
+0.1%
net assets
Total assets minus all liabilities
medicines 4 u ltd company details
company number
05455835
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
May 2005
age
20
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
May 2023
previous names
medicines4u ltd. (February 2015)
accountant
-
auditor
-
address
2nd floor grove house, 55 lowlands road, harrow, HA1 3AW
Bank
-
Legal Advisor
-
medicines 4 u ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 9 charges/mortgages relating to medicines 4 u ltd. Currently there are 3 open charges and 6 have been satisfied in the past.
medicines 4 u ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDICINES 4 U LTD. This can take several minutes, an email will notify you when this has completed.
medicines 4 u ltd Companies House Filings - See Documents
date | description | view/download |
---|